Search

Editas Medicine Inc

Chiusa

SettoreSettore sanitario

3.65 -2.41

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

3.5

Massimo

3.81

Metriche Chiave

By Trading Economics

Entrata

-19M

-25M

Vendite

-22M

2.8M

EPS

-0.26

Margine di Profitto

-882.444

Dipendenti

87

EBITDA

-18M

-23M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+97.26% upside

Dividendi

By Acuity

Utili prossimi

10 ago 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

266M

560M

Apertura precedente

6.06

Chiusura precedente

3.65

Notizie sul Sentiment di mercato

By Acuity

16%

84%

40 / 342 Classifica in Healthcare

Editas Medicine Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

7 lug 2026, 23:51 UTC

News

Netflix is reportedly bidding for FIFA World Cup U.S. rights valued at $2 billion, boosting positive sentiment as shares rise in after-market trading.

7 lug 2026, 23:43 UTC

Social Media
News

Apple Inc. shares rose in after-hours trading, bolstered by a significant gain in a call option and an extended partnership with Broadcom through 2031.

7 lug 2026, 23:41 UTC

News

Concerns over Middle East tensions and rising oil prices support gains in iShares 7-10 Year Treasury Bond ETF during after-hours trading.

7 lug 2026, 23:41 UTC

Social Media
Correlated Moves
News

NVIDIA shares are lower in after-market trading as Michael Burry initiates short positions, citing concerns over reduced AI spending among businesses.

7 lug 2026, 23:41 UTC

Macro News
ETF Constituents
News

Vanguard Information Technology ETF is higher in after-market trading, supported by gains from key holdings despite broader market pressures and geopolitical tensions.

7 lug 2026, 23:41 UTC

ETF Constituents
Social Media
News

Geopolitical tensions following U.S. strikes against Iran have contributed to a decline in Invesco QQQ Trust during after-market hours, reflecting broader market concerns.

7 lug 2026, 23:36 UTC

ETF Constituents
News

Geopolitical tensions following U.S. strikes against Iran have contributed to a decline in the Vanguard Growth ETF during after-market hours.

7 lug 2026, 23:21 UTC

Social Media
News

Meta Platforms Inc. has gained after launching its Muse Image generator, enhancing user engagement despite facing $1.4 trillion in legal challenges.

7 lug 2026, 23:06 UTC

News

Geopolitical tensions rise after U.S. strikes on Iran, while the Reserve Bank of New Zealand is set to announce a rate hike. The ETF traded roughly flat in after-market hours.

7 lug 2026, 23:06 UTC

News

The United States Oil Fund LP is trading higher after military strikes against Iran escalated tensions, contributing to gains in WTI crude prices above $72.50.

7 lug 2026, 23:06 UTC

News
Social Media
Correlated Moves

Micron Technology Inc. shares are lower in after-market trading amid broader market declines and concerns over chip stocks following Samsung's earnings report.

7 lug 2026, 23:02 UTC

Correlated Moves
News

Silver is lower in after-market hours, reflecting declines since Tuesday's close amid rising tensions from U.S. military actions and expectations of a New Zealand rate hike.

7 lug 2026, 23:01 UTC

ETF Constituents
Macro News
News

The Industrial Select Sector SPDR Fund declined in after-market hours amid geopolitical tensions and a hawkish Fed stance, impacting operating margins in the industrial sector.

7 lug 2026, 23:01 UTC

Social Media
News

T-Mobile US Inc. appointed Chris Sambar as Chief Enterprise Officer, effective by October 14, 2026, and shares traded higher in after-market hours.

7 lug 2026, 22:51 UTC

News

PayPal shares are lower in after-market hours following Barclays' Underweight rating and price target of $42.00, amid broader market weakness and geopolitical tensions.

7 lug 2026, 20:07 UTC

News
Correlated Moves

Bitcoin declines amid geopolitical tensions following missile attacks in the Strait of Hormuz. Regulatory approval for Bitcoin Suisse in the UAE adds complexity to investor sentiment.

7 lug 2026, 20:07 UTC

Correlated Moves
News

Bitcoin is lower today amid rising geopolitical tensions and concerns over oil supply disruptions. Ethereum's decline may also influence Bitcoin's price movement.

7 lug 2026, 20:06 UTC

Social Media
News
Correlated Moves

Synopsys Inc. is discontinuing its manufacturing process control software for semiconductor makers, shifting focus to AI design offerings. Shares are trading lower today.

7 lug 2026, 20:06 UTC

Social Media
News

Amazon.com Inc shares are higher following a $25 billion bond sale to fund AI infrastructure, attracting $62 billion in demand and receiving an 'AA-' rating from Fitch.

7 lug 2026, 20:06 UTC

News
Social Media
Correlated Moves

Broadcom Inc shares are lower today following a downgrade to Hold by Erste Group, amid broader declines in the semiconductor sector.

7 lug 2026, 20:06 UTC

News
Correlated Moves

Ethereum is trading lower following a suspicious transaction linked to an exploiter, resulting in estimated losses of around $6 million.

7 lug 2026, 20:04 UTC

News
Social Media

Tesla Inc. shares are lower today amid criticism of CEO Elon Musk's governance linked to negative brand perception, despite RBC raising its price target to $500.

7 lug 2026, 20:03 UTC

Social Media
News

Fiserv is in talks to sell its debit card network for about $15 billion. Shares are trading lower amid market volatility despite earlier gains.

7 lug 2026, 20:03 UTC

News
Correlated Moves

Analog Devices has completed its acquisition of Empower Semiconductor to enhance AI capabilities. Shares are declining amid broader market pressures affecting the semiconductor sector.

7 lug 2026, 20:02 UTC

Correlated Moves
News

IDEXX Laboratories is rising amid strong gains in the Health Care Equipment sector. Analysts highlight IDEXX's innovations as key to maintaining market share.

7 lug 2026, 19:52 UTC

Social Media
News
Correlated Moves

Alphabet Inc. is under investigation in Nigeria for alleged anti-competitive practices, contributing to a decline in shares during Tuesday's session.

7 lug 2026, 19:46 UTC

News
Social Media
Correlated Moves

Costco faces scrutiny from a class-action lawsuit alleging toxic heavy metals in its protein products, contributing to shares trading lower since Monday's close.

7 lug 2026, 19:44 UTC

News

Intuitive Surgical Inc is down today, reversing from earlier gains amid notable volatility. The company continues to benefit from strong market positioning in robotic-assisted surgery.

7 lug 2026, 19:36 UTC

News
Correlated Moves

Ethereum is trading lower amid a suspicious transaction linked to an exploiter, resulting in estimated losses of $6 million and concerns over price manipulation.

7 lug 2026, 19:36 UTC

News
Social Media

Vertex Pharmaceuticals shares are lower today following its $10 billion acquisition of Crinetics Pharmaceuticals, despite analyst support and price target increases.

Confronto tra pari

Modifica del prezzo

Editas Medicine Inc Previsione

Obiettivo di Prezzo

By TipRanks

97.26% in crescita

Previsioni per 12 mesi

Media 7.2 USD  97.26%

Alto 15 USD

Basso 4 USD

Basato su 7 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Editas Medicine Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

7 ratings

5

Acquista

1

Mantieni

1

Vendi

Sentiment

By Acuity

40 / 342 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Editas Medicine Inc

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 BRILLIANCE trial for Leber Congenital Amaurosis; and reni-cel, a clinical development gene-edited medicine to treat sickle cell disease and transfusion-dependent beta-thalassemia. In addition, the company is developing alpha-beta T cells for solid and liquid tumors; and gamma delta T cell therapies to treat cancer. It has a research collaboration with Juno Therapeutics, Inc. to develop engineered T cells for cancer; collaboration and nonexclusive license agreement with Genevant Sciences to develop Novel mRNA-LNP gene editing therapeuticsand strategic alliance and option agreement with Allergan Pharmaceuticals International Limited, as well as collaboration with Bristol Myers Squibb for research and development of alpha-beta T cell medicines for the treatment of cancer and autoimmune diseases. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.
help-icon Live chat